The editors and staff at the AGA issue the following erratum to the previous correction to this review because the correction contains information about a matter that is still under review in the judicial system. This was partially acknowledged in the AGA Technical Review with the following statement: “At time of publication, litigation between the manufacturer of VSL#3 and Dr.De Simone/ExeGi Pharma over intellectual property claims was ongoing.”